Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Caleb Capital appears to be a small financial services and investment firm rather than a biotech, pharma, or healthcare operating company. Available third-party business databases describe it as an asset management or investment organization, with references to investing in sectors such as medical health alongside other industries. However, there is no clear evidence that Caleb Capital itself develops therapeutics, diagnostics, medical devices, or healthcare services. The entity also appears fragmented across multiple business-listing records and may have been inactive or deadpooled in at least one tracked profile. Based on currently available information, it should not be classified as a life sciences company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Caleb Capital.